Moderna covid-19 vaccine clinical trial for people with organ transplant starts at feinstein institutes

Manhasset, n.y.--(business wire)--in a new clinical trial looking at the efficacy of a third moderna vaccine dose for coronavirus disease 2019 (covid-19) in people living with an organ (liver or kidney) transplant, the feinstein institutes for medical research – the science arm of northwell health – administered the extra vaccine to the first set of patients in the united states on september 20. the multi-centered, nationwide clinical trial is sponsored by the vaccine-maker moderna. people who
MRNA Ratings Summary
MRNA Quant Ranking